GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » VolitionRX Ltd (AMEX:VNRX) » Definitions » Cyclically Adjusted PB Ratio

VolitionRX (VolitionRX) Cyclically Adjusted PB Ratio : 2.34 (As of Apr. 27, 2024)


View and export this data going back to 2007. Start your Free Trial

What is VolitionRX Cyclically Adjusted PB Ratio?

As of today (2024-04-27), VolitionRX's current share price is $0.9137. VolitionRX's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $0.39. VolitionRX's Cyclically Adjusted PB Ratio for today is 2.34.

The historical rank and industry rank for VolitionRX's Cyclically Adjusted PB Ratio or its related term are showing as below:

VNRX' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.58   Med: 144.5   Max: 297.5
Current: 2.26

During the past years, VolitionRX's highest Cyclically Adjusted PB Ratio was 297.50. The lowest was 1.58. And the median was 144.50.

VNRX's Cyclically Adjusted PB Ratio is ranked worse than
59.54% of 131 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.98 vs VNRX: 2.26

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

VolitionRX's adjusted book value per share data for the three months ended in Dec. 2023 was $-0.095. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.39 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


VolitionRX Cyclically Adjusted PB Ratio Historical Data

The historical data trend for VolitionRX's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VolitionRX Cyclically Adjusted PB Ratio Chart

VolitionRX Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.30 12.86 8.44 6.24 1.82

VolitionRX Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.24 4.86 3.50 1.73 1.82

Competitive Comparison of VolitionRX's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, VolitionRX's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VolitionRX's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, VolitionRX's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where VolitionRX's Cyclically Adjusted PB Ratio falls into.



VolitionRX Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

VolitionRX's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.9137/0.39
=2.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VolitionRX's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, VolitionRX's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.095/129.4194*129.4194
=-0.095

Current CPI (Dec. 2023) = 129.4194.

VolitionRX Quarterly Data

Book Value per Share CPI Adj_Book
201403 -0.125 99.695 -0.162
201406 -0.040 100.560 -0.051
201409 -0.286 100.428 -0.369
201412 0.025 99.070 0.033
201503 0.618 99.621 0.803
201506 0.522 100.684 0.671
201509 0.395 100.392 0.509
201512 0.322 99.792 0.418
201603 0.723 100.470 0.931
201606 0.609 101.688 0.775
201609 0.500 101.861 0.635
201612 0.810 101.863 1.029
201703 0.707 102.862 0.890
201706 0.627 103.349 0.785
201709 0.505 104.136 0.628
201712 0.375 104.011 0.467
201803 0.467 105.290 0.574
201806 0.335 106.317 0.408
201809 0.431 106.507 0.524
201812 0.344 105.998 0.420
201903 0.400 107.251 0.483
201906 0.415 108.070 0.497
201909 0.433 108.329 0.517
201912 0.345 108.420 0.412
202003 0.223 108.902 0.265
202006 0.400 108.767 0.476
202009 0.395 109.815 0.466
202012 0.336 109.897 0.396
202103 0.590 111.754 0.683
202106 0.503 114.631 0.568
202109 0.401 115.734 0.448
202112 0.334 117.630 0.367
202203 0.207 121.301 0.221
202206 0.083 125.017 0.086
202209 0.057 125.227 0.059
202212 -0.044 125.222 -0.045
202303 -0.037 127.348 -0.038
202306 0.075 128.729 0.075
202309 -0.026 129.860 -0.026
202312 -0.095 129.419 -0.095

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


VolitionRX  (AMEX:VNRX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


VolitionRX Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of VolitionRX's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


VolitionRX (VolitionRX) Business Description

Traded in Other Exchanges
N/A
Address
1489 West Warm Springs Road, Suite 110, Henderson, NV, USA, 89014
VolitionRX Ltd is a United states based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Executives
Eight Corp Ltd 10 percent owner C/O CROWE MORGAN, 8 ST. GEORGE'S STREET, DOUGLAS Y8 IM1 1AH
Salvatore Thomas Butera director 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Rodney Gerard Rootsaert director, officer: SECRETARY 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Cameron John Reynolds director, officer: PRESIDENT AND CEO 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Guy Archibald Innes director 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Edward Futcher director 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Phillip Barnes director 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Martin Charles Faulkes director 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Mickie Henshall director 1489 WEST WARM SPRINGS ROAD,, SUITE 110, HENDERSON NV 89014
Jacob Vincent Micallef officer: Chief Scientific Officer 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Michel Gaetan other: Manager Belgian Volition SPRL 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Jasmine Kway other: CEO-Singapore Volition 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Nicholas Plummer officer: GC - Volition Diagnostics 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Ann-louise Batchelor officer: Group Chief Marketing Officer 1489 WEST WARM SPRINGS ROAD,, SUITE 110, HENDERSON NV 89014
Terrell Jason Bradley Md officer: Chief Medical Officer 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014